<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Innovations

SuviCa, CU Boulder, and CU Anschutz Announce Positive FDA Pre-IND Feedback for SVC112 Program in Advanced Solid Tumors

Default sub title

minute read

by Columbus Dispatch | July 7, 2026
placeholder

Topics: Press Coverage

Related Articles

Partners

Children's Hospital of Colorado Center for Innovation

Colorado Clinical and Translational Sciences Institute

Fitzsimons Innovation Community

UCHealth Innovation Center

© 2025  The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.